MarineMax
HZO Small CapConsumer Cyclical · Specialty Retail
Mis à jour: Aug 2, 2026, 22:14 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
MarineMax en bref
MarineMax (HZO) is currently trading at 29,89 € with a market capitalization of 658 M €. The trailing P/E ratio stands at 215.44x, with a forward P/E of 21.66x. The 52-week range spans from 18,57 € to 33,07 €; the current price is 9.6% below the yearly high. Year-over-year revenue growth stands at -7.0%. The net profit margin stands at 0.18%.
💰 Dividende
MarineMax currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
7 analystes évaluent MarineMax (HZO) au consensus : Acheter. L'objectif de cours moyen est de 32,82 €, soit un potentiel de +9.83% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 30,35 € à 35,55 €.
MarineMax : la thèse d'investissement en détail
MarineMax (HZO) operates in the Consumer Cyclical — specifically Specialty Retail — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario baissier
Revenue is contracting at -7% year-over-year — until that trend reverses, valuation is exposed to further downgrades. With a net margin of just 0.18%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. A trailing P/E above 50 combined with revenue growth below 20% is a dangerous combination — the market is paying a steep growth multiple for what is, by the data, only moderately fast expansion.
Valorisation en contexte
The PEG ratio at 1.09 sits in the reasonable zone — the price tag is roughly aligned with the company's growth profile, neither punishing nor euphoric.
À surveiller
- The forward P/E of 21.66x is meaningfully below the trailing 215.44x — analysts expect earnings to step up; the next earnings release is the test.
Thèse d'investissement : forces et faiblesses
- Consensus des analystes : Buy
- Free cash flow positif
- –CA en contraction (-7% sur un an)
- –Faible rentabilité (marge 0.18%)
- –Multiple de valorisation élevé (P/E 215.44x)
- –Actuellement jugée surévaluée
- –Positions vendeuses élevées (16.23%)
Aperçu technique
Price shows short-term weakness (below 50d MA) but is still in a longer-term uptrend (above 200d MA).
Profil de risque
The data points to above-average price swings, elevated short interest (16.23%), higher leverage relative to equity.
Trading Data
Related Stocks in the Same Sector
More Consommation Cyclique stocks
Top peers in the same sector — ranked by market cap.
Where can I buy MarineMax?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
📊 Plutôt un fonds qu’une action isolée ? Comparatif d’ETF :
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
